تجاوز إلى المحتوى الرئيسي

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

Pediatric Bone Marrow Transplant Fellowship

Program Description and Goals

Pediatric Hematopoietic Stem Cell Transplant/ Immunotherapy Fellowship

Phoenix Children’s Hospital (PCH) and the Centers for Cancer and Blood Disorders (CCBD) offers a one-year non-ACMGE accredited Pediatric Hematopoietic Stem Cell Transplant/Immunotherapy fellowship. The fellowship is open to qualified physicians who are board certified in pediatrics, have completed three years of pediatric hematology/oncology fellowship training open to pursuing further training in transplant and cellular therapy.

Pediatric Hematology and Oncology fellowship training requirements do not include sufficient experience in the field of cellular therapies/transplant to provide competency in the field in accordance with current FACT standards. Therefore, there is a need for training programs to offer this experience and expertise.

Our curriculum includes exposures to both hematopoietic stem cell transplant and immunotherapy as well as provides opportunity for research. Fellows will have clinical experience in the following areas:

  • BMT inpatient service (including management of CAR-T cell patients)
  • BMT outpatient clinic (including management of CAR-T cell patients)
  • Immunohematology outpatient clinic
  • Research
  • Elective opportunities in: Transfusion Medicine, HLA lab, Radiation Oncology, or the stem cell lab
  • Opportunities for development of additional teaching skills as they will provide didactics and supervision of junior fellows during their tenure
  • Four weeks of vacation are offered with up to 5 days of CME

By the completion of Hematopoietic Stem Cell Transplant training, trainees should have achieved the following goals:

  1. Develop a sound understanding of underlying pathophysiological principles of HSCT, including those of hematopoiesis and immunology
  2. Become clinically competent in the care of pediatric patients with non-malignant and malignant disorders treated by BMT
  3. Achieve competency in the procedural and technical skills required in the evaluation and care of HCT recipients

    Program Duration and Important Dates:

    • Fellowship start date: July 1, 2023
    • Fellowship end date: June 30, 2024
    • Application start date: August 1, 2022
    • Application deadline: December 31, 2022

    Eligibility:

    • Completion of three years of pediatric hematology/oncology fellowship training
    • Board certified in general pediatrics
    • Board eligible or board certified in pediatric hematology/oncology in the United States

    Be able to obtain an Arizona Medical license

    Contact

    Ozzie Rodriguez
    GME Program Administrator
    602-933-3132
    orodriguez1@phoenixchildrens.com

    Holly K. Miller, DO
    Program Director
    hmiller2@phoenixchildrens.com

     

    Share this page